CAMLG
calcium modulating ligand
CAMLG; calcium modulating ligand; calcium signal-modulating cyclophilin ligand; calcium modulating cyclophilin ligand; calcium signal modulating cyclophilin ligand; CAML; cyclophilin B binding protein; MGC163197; cyclophilin B-binding protein; calcium-modulating cyclophilin ligand; calcium-signal modulating cyclophilin ligand; AI385748;
CCL1
chemokine (C-C motif) ligand 1
CCL1; chemokine (C-C motif) ligand 1; C-C motif chemokine 1; P500; TCA3; CCR8 ligand; SIS-epsilon; T-cell activation protein 3; small inducible cytokine A1; small-inducible cytokine A1; I-309; Scya1; Tca-3; BF534335; Ccl1;
CCL11
chemokine (C-C motif) ligand 11
Ccl11; chemokine (C-C motif) ligand 11; Scya11; eotaxin; eotaxin-1; MGC22554; small inducible cytokine subfamily A (Cys-Cys), member 11 (eotaxin); small inducible cytokine A11; C-C motif chemokine 11; Eosinophil chemotactic protein;
Ccl12
chemokine (C-C motif) ligand 12
CCL12; chemokine (C-C motif) ligand 12; C-C motif chemokine 12; Macrophage/monocyte Chemotactic Protein; OTTMUSP00000000792; Scya12; Small inducible cytokine A12; MCP-1-related chemokine; small-inducible cytokine A12; monocyte chemotactic protein 5; monocyte chemoattractant protein 5; MCP-5;
CCL13
chemokine (C-C motif) ligand 13
CCL13; chemokine (C-C motif) ligand 13; NCC1; CKb10; MCP-4; NCC-1; SCYL1; SCYA13; MGC17134; C-C motif chemokine 13; CK-beta-10; OTTHUMP00000163804; new CC chemokine 1; small-inducible cytokine A13; monocyte chemotactic protein 4; monocyte chemoattractant protein 4; small inducible cytokine subfamily A (Cys-Cys), member 13; MCP4;
CCL14
chemokine (C-C motif) ligand 14
CCL14; SCYA14; HCC-1; HCC-3; NCC-2; SCYL2; CKb1; MCIF; Hemofiltrate CC Chemokine 1;
CCL15
chemokine (C-C motif) ligand 15
LKN1; NCC3; SY15; HCC-2; Lkn-1; MIP-5; NCC-3; SCYL3; MIP-1d; SCYA15; HMRP-2B; chemokine (C-C motif) ligand 15; CCL15_HUMAN; MIP5; C-C motif chemokine 15 [Precursor]; Small-inducible cytokine A15; Macrophage inflammatory protein 5; Chemokine CC-2; MIP-1delta; Leukotactin-1; Mrp-2b; small inducible cytokine subfamily A (Cys-Cys), member 15; CCL15;
CCL16
chemokine (C-C motif) ligand 16
CCL16; chemokine (C-C motif) ligand 16; SCYA16, small inducible cytokine subfamily A (Cys Cys), member 16; C-C motif chemokine 16; CKb12; HCC 4; LCC 1; LEC; LMC; Mtn 1; NCC 4; SCYL4; CCL16_HUMAN; Chemokine CC-4; Chemokine LEC; HCC-4; HCC4; IL-10-inducible chemokine; IL10 inducible chemokine; ILINCK; LCC-1; LCC1; Liver CC chemokine 1 precursor; Liver expressed chemokine; Liver-expressed chemokine; Lymphocyte and monocyte chemoattractant; Monotactin 1; Monotactin-1; MTN-1; Mtn1; NCC-4; NCC4; New CC chemokine 4; SCYA16; Small inducible cytokine A16 precursor; Small inducible cytokine subfamily A (Cys Cys) member 16; Small-inducible cytokine A16; OTTHUMP00000163951; liver CC chemokine-1; small indu;
CCL17
chemokine (C-C motif) ligand 17
CCL17; A-152E5.3; ABCD-2; MGC138271; MGC138273; SCYA17; TARC; CC chemokine TARC; C-C motif chemokine; chemokine (C-C motif) ligand 17; small inducible cytokine subfamily A (Cys-Cys), member 17; Small-inducible cytokine A17; Thymus and activation-regulated chemokine;
CCL18
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
CCL18; chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated); CKb7; PARC; AMAC1; DCCK1; MIP-4; AMAC-1; DC-CK1; SCYA18; C-C motif chemokine 18; CC chemokine PARC; OTTHUMP00000163954; CC chemokine ligand 18; chemokine (C-C), dendritic; dendritic cell chemokine 1; small inducible cytokine A18; small-inducible cytokine A18; macrophage inflammatory protein 4; pulmonary and activation-regulated chemokine; alternative macrophage activation-associated CC chemokine 1; small inducible cytokine subfamily A (Cys-Cys), member 18, pulmonary and activation-regulated;
CCL19
Chemokine (C-C motif) ligand 19
CCL19; RP11-195F19.11-003; CKb11; ELC; MIP-3b; MIP3B; SCYA19; C-C motif chemokine 19; CC chemokine ligand 19; CK beta-11; EBI1 ligand chemokine; EBI1-ligand chemokine; beta chemokine exodus-3; beta-chemokine exodus-3; epstein-Barr virus-induced molecule 1 ligand chemokine; exodus-3; macrophage inflammatory protein 3 beta; macrophage inflammatory protein 3-beta; small inducible cytokine subfamily A (Cys-Cys), member 19; small-inducible cytokine A19;
CCL2
chemokine (C-C motif) ligand 2
CCL2; chemokine (C-C motif) ligand 2; HC11; MCAF; MCP1; MCP-1; SCYA2; GDCF-2; SMC-CF; HSMCR30; C-C motif chemokine 2; small-inducible cytokine A2; monocyte secretory protein JE; monocyte chemotactic protein 1; monocyte chemoattractant protein 1; monocyte chemoattractant protein-1; monocyte chemotactic and activating factor; small inducible cytokine subfamily A (Cys-Cys), member 2; small inducible cytokine A2 (monocyte chemotactic protein 1, homologous to mouse Sig-je);
CCL20
chemokine (C-C motif) ligand 20
CCL20; chemokine (C-C motif) ligand 20; CKb4; LARC; ST38; MIP3A; MIP-3a; SCYA20; C-C motif chemokine 20; exodus-1; MIP-3-alpha; CC chemokine LARC; OTTHUMP00000164245; OTTHUMP00000204113; beta chemokine exodus-1; beta-chemokine exodus-1; small-inducible cytokine A20; macrophage inflammatory protein 3 alpha; liver and activation-regulated chemokine; small inducible cytokine subfamily A (Cys-Cys), member 20; MIP-3[a]; OTTMUSP00000017965; OTTMUSP00000017966;
CCL21
chemokine (C-C motif) ligand 21
SLC protein, Exodus 2, Exodus-2 protein, 6Ckine protein, Exodus-2 protein, Exodus 2, Exodus 2 protein, Exodus-2, CCL21 protein;
Ccl21c
chemokine (C-C motif) ligand 21C (leucine)
CCL21C;chemokine (C-C motif) ligand 21C (leucine);C-C motif chemokine 21c;6Ckine;Ccl21-leu;C-C motif chemokine 21b;beta chemokine exodus-2;beta-chemokine exodus-2;Small-inducible cytokine A21b;small inducible cytokine A21c;small-inducible cytokine A21c;thymus-derived chemotactic agent 4;SLC;CKb9;TCA4;Ccl21b;Scya21;Scya21b;Scya21c;exodus-2;
CCL22
CCL22 chemokine (C-C motif) ligand 22
CCL22; chemokine (C-C motif) ligand 22; MDC; ABCD-1; SCYA22; STCP-1; DC/B-CK; MGC34554; A-152E5.1; C-C motif chemokine 22; MDC(1-69); OTTHUMP00000164658; CC chemokine STCP-1; macrophage-derived chemokine; small inducible cytokine A22; small-inducible cytokine A22; stimulated T cell chemotactic protein 1; stimulated T-cell chemotactic protein 1; small inducible cytokine subfamily A (Cys-Cys), member 22;
CCL23
CCL23 chemokine (C-C motif) ligand 23
CCL23; chemokine (C-C motif) ligand 23; SCYA23, small inducible cytokine subfamily A (Cys Cys), member 23; C-C motif chemokine 23; Ckb 8; CKb8; MIP 3; MPIF 1; hmrp-2a; C6 beta-chemokine; small-inducible cytokine A23; macrophage inflammatory protein 3; myeloid progenitor inhibitory factor 1; small inducible cytokine subfamily A (Cys-Cys), member 23; MIP3; Ckb-8; MIP-3; MPIF-1; SCYA23; Ckb-8-1; CK-BETA-8;
CCL24
chemokine (C-C motif) ligand 24
Ckb-6; MPIF-2; MPIF2; SCYA24; C-C motif chemokine 24; CK-beta-6; eosinophil chemotactic protein 2; eotaxin-2; myeloid progenitor inhibitory factor 2; small inducible cytokine subfamily A (Cys-Cys), member 24; small-inducible cytokine A24;
CCL25
chemokine (C-C motif) ligand 25
CCL25; chemokine (C-C motif) ligand 25; C-C motif chemokine 25; thymus-expressed chemokine; small inducible chemokine 25; small inducible cytokine A25; TECK; CKb15; Scya25; AI852536; A130072A22Rik;
CCL26
chemokine (C-C motif) ligand 26
CCL26; chemokine (C-C motif) ligand 26; SCYA26, small inducible cytokine subfamily A (Cys Cys), member 26; C-C motif chemokine 26; CC chemokine IMAC; chemokine N1; eotaxin 3; IMAC; macrophage inflammatory protein 4 alpha; MIP 4a; MIP 4alpha; small inducible cytokine A26; thymic stroma chemokine 1; TSC 1; CCL 26; CCL26_HUMAN; Chemokine (C C motif) ligand 26; Eotaxin-3; macrophage inflammatory protein 4-alpha; MIP-4-alpha; MIP4a; MIP4alpha; SCYA 26; SCYA26; Small inducible cytokine subfamily A (Cys Cys) member 26; Small inducible cytokine subfamily A member 26; Small-inducible cytokine A26; Thymic stroma chemokine-1; TSC-1; TSC1; OTTHUMP00000160954; OTTHUMP00000210227; small inducible c; MIP-4a; MIP-4alpha;
CCL27
chemokine (C-C motif) ligand 27
CCL27; chemokine (C-C motif) ligand 27; SCYA27, small inducible cytokine subfamily A (Cys Cys), member 27; C-C motif chemokine 27; ALP; CC chemokine ILC; CTACK; CTAK; cutaneous T cell attracting chemokine; ESkine; IL 11 Ralpha locus chemokine; ILC; PESKY;
Ccl27a
chemokine (C-C motif) ligand 27A
CCL27A;chemokine (C-C motif) ligand 27A;C-C motif chemokine 27;skinkine;skinskine;CC chemokine ILC;small inducible cytokine A27;small-inducible cytokine A27;IL-11 R-alpha-locus chemokine;small inducible cytokine A27a;chemokine (C-C motif) ligand 27;cutaneous T-cell-attracting chemokine;ALP;ILC;CTAK;CTACK;Ccl27;PESKY;ESkine;Scya27;Scya27a;AW558992;MGC130150;
CCL3
chemokine (C-C motif) ligand 3
Ccl3; chemokine (C-C motif) ligand 3; Mip1a; Scya3; G0S19-1; AI323804; MIP1-(a); LD78alpha; MIP-1alpha; MIP1-alpha; C-C motif chemokine 3; TY-5; L2G25B; MIP1 (a); SIS-alpha; MIP-1 alpha; MIP-1-alpha; OTTMUSP00000000942; small inducible cytokine A3; small-inducible cytokine A3; heparin-binding chemotaxis protein; macrophage inflammatory protein-1alpha; macrophage inflammatory protein 1-alpha;
CCL3L1
chemokine (C-C motif) ligand 3-like 1
CCL3L1;chemokine (C-C motif) ligand 3-like 1;D17S1718, SCYA3L, SCYA3L1, small inducible cytokine A3 like 1;C-C motif chemokine 3-like 1;G0S19 2;LD78BETA;PAT 464.2;LD78-beta(1-70);small inducible cytokine A3-like 1;small-inducible cytokine A3-like 1;G0/G1 switch regulatory protein 19-2;tonsillar lymphocyte LD78 beta protein;LD78;464.2;MIP1AP;SCYA3L;G0S19-2;SCYA3L1;D17S1718;MGC12815;MGC104178;MGC182017;
Ccl4
chemokine (C-C motif) ligand 4
Ccl4; chemokine (C-C motif) ligand 4; MIP-1b; MIP 1 beta; Secreted protein G 26; ACT 2; ACT-2; ACT2; AT744.1; CC chemokine ligand 4; CCL4; CCL4_HUMAN; ccl4l 1; CCL4L1; Chemokine CC Motif Ligand 4; G 26 T lymphocyte secreted protein; G-26 T-lymphocyte-secreted protein; HC21; LAG 1; LAG-1; LAG1; Lymphocyte activation gene 1; Lymphocyte activation gene 1 protein; Macrophage inflammatory protein 1 beta; Macrophage inflammatory protein 1-beta; MGC104418; MGC126025; MGC126026; MIP-1-beta; MIP-1-beta(1-69); MIP-1-beta(3-69); MIP1 beta; MIP1B; MIP1B1; PAT 744; Protein H400; SCYA2; SCYA4; Secreted protein G26; SIS gamma; SIS-gamma; Small inducible cytokine A4; Small-inducible cytokine A4; T cell activation protein 2; T-cell activation protein 2; MIP-1β; Macrophage inflammatory protein-1β;
CCL5
chemokine (C-C motif) ligand 5
CCL5; chemokine (C-C motif) ligand 5; SISd; eoCP; SCYA5; RANTES; TCP228; D17S136E; SIS-delta; C-C motif chemokine 5; beta-chemokine RANTES; T-cell specific protein p288; eosinophil chemotactic cytokine; small inducible cytokine subfamily A (Cys-Cys), member 5; regulated upon activation, normally T-expressed, and presumably secreted;
Ccl6
chemokine (C-C motif) ligand 6
CCL6; chemokine (C-C motif) ligand 6; C-C motif chemokine 6; C10; CCL 6; Chemokine C C motif Ligand 6; Chemokine C-C motif Ligand 6; MRP1; SCYA6; Small Inducible Cytokine A6; CC chemokine C10; small-inducible cytokine A6; MRP-1;
CCL7
chemokine (C-C motif) ligand 7
RP23-350G1.4; MCP-3; Scya7; fic; marc; mcp3; C-C motif chemokine 7; RANTES/sis homolog; intercrine/chemokine MARC; monocyte chemoattractant protein 3; monocyte chemotactic protein 3; small inducible cytokine A7; small-inducible cytokine A7;
CCL8
chemokine (C-C motif) ligand 8
CCL8; chemokine (C-C motif) ligand 8; SCYA8, small inducible cytokine subfamily A (Cys Cys), member 8 (monocyte chemotactic protein 2); C-C motif chemokine 8; HC14; MCP 2; small-inducible cytokine A8; monocyte chemotactic protein 2; monocyte chemoattract;
Ccl9
chemokine (C-C motif) ligand 9
CCL9; chemokine (C-C motif) ligand 9; C-C motif chemokine 9; MIP-1 gamma; small inducible cytokine A9; small inducible cytokine A10; macrophage inflammatory protein 1-gamma; macrophage inflammatory protein-related protein 2; CCF18; MRP-2; Scya9; Scya10;
CD40LG
CD40 ligand
CD40LG; CD40 ligand; IGM; IMD3; TRAP; gp39; CD154; CD40L; HIGM1; T-BAM; TNFSF5; hCD40L; CD40-L; CD40 antigen ligand; T-cell antigen Gp39; T-B cell-activating molecule; TNF-related activation protein; tumor necrosis factor (ligand) superfamily member 5; tu;
CX3CL1
chemokine (C-X3-C motif) ligand 1
CX3CL1; chemokine (C-X3-C motif) ligand 1; NTN; NTT; CXC3; CXC3C; SCYD1; ABCD-3; C3Xkine; fractalkine; neurotactin; fractalkine; C-X3-C motif chemokine 1; small-inducible cytokine D1; CX3C membrane-anchored chemokine; small inducible cytokine subfamily D (Cys-X3-Cys), member-1; small inducible cytokine subfamily D (Cys-X3-Cys), member 1 (fractalkine, neurotactin);
CXCL1
chemokine (C-X-C motif) ligand 1
CXCL1; chemokine (C-X-C motif) ligand 1; KC; Fsp; N51; gro; Gro1; Mgsa; Scyb1; growth-regulated alpha protein; KC/GR)-alpha; KC/GRO-alpha; GRO1 oncogene; alpha-chemokine; secretory protein N51; C-X-C motif chemokine 1; platelet-derived growth factor-inducible protein KC;
Cxcl10
chemokine (C-X-C motif) ligand 10
CXCL10; chemokine (C-X-C motif) ligand 10; C7; IFI10; INP10; IP-10; crg-2; mob-1; SCYB10; gIP-10; C-X-C motif chemokine 10; gamma IP10; gamma-IP10; small-inducible cytokine B10; interferon-inducible cytokine IP-10; 10 kDa interferon gamma-induced protein; protein 10 from interferon (gamma)-induced cell line; small inducible cytokine subfamily B (Cys-X-Cys), member 10;
CXCL11
chemokine (C-X-C motif) ligand 11
CXCL11; chemokine (C-X-C motif) ligand 11; SCYB9B, SCYB11, small inducible cytokine subfamily B (Cys X Cys), member 11; C-X-C motif chemokine 11; b R1; H174; I TAC; IP 9; beta-R1; small inducible cytokine B11; small-inducible cytokine B11; interferon gam;
CXCL12
chemokine (C-X-C motif) ligand 12
CXCL12; chemokine (C-X-C motif) ligand 12; SDF1, SDF1A, SDF1B, stromal cell derived factor 1; stromal cell-derived factor 1; PBSF; SCYB12; SDF 1a; SDF 1b; TLSF a; TLSF b; TPAR1; intercrine reduced in hepatomas; pre-B cell growth-stimulating factor; IRH; SDF1; TLSF; SDF1A; SDF1B;
CXCL13
chemokine (C-X-C motif) ligand 13
ANGIE; ANGIE2; BCA-1; BCA1; BLC; BLR1L; SCYB13; B-cell chemoattractant; B-cell-attracting chemokine 1; B-cell-homing chemokine (ligand for Burkitts lymphoma receptor-1); B-lymphocyte chemoattractant; C-X-C motif chemokine 13; CXC chemokine BLC; b cell-attracting chemokine 1; b lymphocyte chemoattractant; chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant); small inducible cytokine B subfamily (Cys-X-Cys motif), member 13 (B-cell chemoattractant); small-inducible cytokine B13;
CXCL14
chemokine (C-X-C motif) ligand 14
CXCL14; chemokine (C-X-C motif) ligand 14; KEC; KS1; BMAC; BRAK; NJAC; MIP2G; MIP-2g; SCYB14; C-X-C motif chemokine 14; bolekine; MIP-2 gamma; chemokine BRAK; breast and kidney; tumor-suppressing chemokine; small-inducible cytokine B14; CXC chemokine in breast and kidney; small inducible cytokine subfamily B (Cys-X-Cys), member 14 (BRAK);
Cxcl15
chemokine (C-X-C motif) ligand 15
CXCL15; chemokine (C-X-C motif) ligand 15; C-X-C motif chemokine 15; small-inducible cytokine B15; small inducible cytokine subfamily B, member 15; weche; Scyb15; lungkine;
Cxcl16
chemokine (C-X-C motif) ligand 16
chemokine (C-X-C motif) ligand 16; SRPSOX; CXCLG16; SR-PSOX; CXCL16; CXC chemokine ligand 16; Scavenger receptor for phosphatidylserine and oxidized low density lipoprotein; Small-inducible cytokine B16; Transmembrane chemokine CXCL16;
Cxcl2
chemokine (C-X-C motif) ligand 2
GROb; Gro2; Mip2; Scyb; MIP-2; Scyb2; MIP-2a; Mgsa-b; CINC-2a; Cxcl2; chemokine (C-X-C motif) ligand 2;
CXCL3
chemokine (C-X-C motif) ligand 3
Cxcl3; Cinc2; Cinc-2; Gm1960; chemokine (C-X-C motif) ligand 3; GRO-gamma; SCYB3; GRO-gamma(1-73); GRO3; MIP2-beta; CINC-2b; MIP2B; GROg; MIP-2b; C-X-C motif chemokine 3; GRO3 oncogene; melanoma growth stimulatory activity gamma; Growth-regulated protein gamma; MGSA gamma2; Macrophage inflammatory protein 2-beta; GROG; C-X-C motif chemokine 3; MIP2-alpha/beta; macrophage inflammatory protein 2-alpha/beta; cytokine-induced neutrophil chemoattractant 2; cytokine-induced neutrophil chemoattractant-2;
CXCL9
chemokine (C-X-C motif) ligand 9
CXCL9; chemokine (C-X-C motif) ligand 9; C-X-C motif chemokine 9; M119; protein m119; small-inducible cytokine B9; gamma interferon-induced monokine; gamma-interferon-induced monokine; monokine induced by gamma interferon; monokine induced by interferon-gamma; small inducible cytokine B subfamily (Cys-X-Cys), member 9; CMK; Mig; MuMIG; Scyb9; crg-10; BB139920;
FASLG
Fas ligand (TNF superfamily, member 6)
FASLG; Fas ligand (TNF superfamily, member 6); FASL; CD178; CD95L; CD95-L; TNFSF6; APT1LG1; tumor necrosis factor ligand superfamily member 6; APTL; CD95 ligand; OTTHUMP00000032708; fas antigen ligand; apoptosis antigen ligand; apoptosis (APO-1) antigen ligand 1; tumor necrosis factor (ligand) superfamily, member 6; soluble form; APO1L; Apoptosis antigen ligand 1; CD178 antigen; CD95; L CD95L protein; Fas L; Fas ligand; Fasl Fas ligand (TNF superfamily member 6); Generalized lymphoproliferative disease; Gld; TNF superfamily member 6; TNFL6_HUMAN; Fas-L;
FCAR
Fc fragment of IgA, receptor for
FCAR; Fc fragment of IgA, receptor for; immunoglobulin alpha Fc receptor; CD89; Fc alpha receptor; FCAR_HUMAN; IgA Fc receptor; OTTHUMP00000068691; OTTHUMP00000068692; OTTHUMP00000068693; OTTHUMP00000068694; OTTHUMP00000068695; OTTHUMP00000068696; OTTHUMP00000068697; OTTHUMP00000068698;
FLT3LG
Fms-related tyrosine kinase 3 ligand
Flt 3 ligand; Flt 3L; Flt3 L; FLT3 LG; Flt3 ligand; Flt3L; FLT3L_HUMAN; Flt3lg; Fms related tyrosine kinase 3 ligand; Fms-related tyrosine kinase 3 ligand; SL cytokine; Flt3lg;
GLUL
glutamate-ammonia ligase
GLUL; glutamate-ammonia ligase; GS; GLNS; PIG43; PIG59; glutamine synthetase; glutamine synthase; glutamate decarboxylase; glutamate--ammonia ligase; proliferation-inducing protein 43; cell proliferation-inducing protein 59;
Icosl
icos ligand
ICOSL; icos ligand; B7 H2; B7 homolog 2; B7 like protein Gl50; B7 related protein 1; B7-H2; B7-like protein Gl50; B7-related protein 1; B7H2; B7RP 1; B7RP-1; B7RP1; CD 275; CD275; CD275 antigen; GL 50; GL50; ICOS LG; ICOSL_HUMAN; ICOSLG; Inducible T cell co stimulator ligand; KIAA0653; LICOS; Transmembrane protein B7 H2 ICOS ligand; B7h; GI50; GL50-B; ICOS-L; Ly115l; AU044799; BG071784; mKIAA0653;
ICOSLG
inducible T-cell co-stimulator ligand
ICOSLG; inducible T-cell co-stimulator ligand; ICOSL; ICOS ligand; B7 homolog 2; B7 homologue 2; B7 H2; B7 related protein 1; B7H2; B7RP 1; B7RP1; CD275; GL50; ICOS L; KIAA0653; B7-like protein Gl50; B7-related protein 1; transmembrane protein B7-H2 ICOS ligand; B7-H2; LICOS; B7RP-1; ICOS-L;
ITCH
itchy E3 ubiquitin protein ligase
ITCH; itchy E3 ubiquitin protein ligase; AIF4; AIP4; NAPP1; dJ468O1.1; E3 ubiquitin-protein ligase Itchy homolog; NFE2-associated polypeptide 1; atrophin-1 interacting protein 4; itchy E3 ubiquitin protein ligase homolog; dJ468O1.1 (atrophin 1 interacting protein 4 (AIP4));
Kitlg
KIT ligand
KITLG; KIT ligand; SF; MGF; SCF; FPH2; KL-1; Kitl; SHEP7; c-Kit ligand; steel factor; stem cell factor; mast cell growth factor; familial progressive hyperpigmentation 2; Clo; Con; Gb; SLF; Sl; contrasted; cloud gray; grizzle-belly; hematopoietic growth factor KL; stem cell factor Location: 10 51.4 cM;
Map3k1
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
MAP3K1; mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase; MEKK1, mitogen activated protein kinase kinase kinase 1; mitogen-activated protein kinase kinase kinase 1; MAPKKK1; MEKK; MEK kinase 1; MAP/ERK kinase kinase 1; MAPK/ERK kinase kinase 1; MEKK1; SRXY6; MEKK 1;
MDM2
MDM2 oncogene, E3 ubiquitin protein ligase
MDM2; MDM2 oncogene, E3 ubiquitin protein ligase; HDMX; hdm2; ACTFS; E3 ubiquitin-protein ligase Mdm2; oncoprotein Mdm2; Mdm2, p53 E3 ubiquitin protein ligase homolog; double minute 2, human homolog of; p53-binding protein; Mdm2, transformed 3T3 cell double minute 2, p53 binding protein;
MTHFS
5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase)
MTHFS; 5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase); 5-formyltetrahydrofolate cyclo-ligase; HsT19268; 10-methenyl-tetrahydrofolate synthetase; 5; 5 formyltetrahydrofolate cyclo ligase; 5,10 methenyl tetrahydrofolate synthetase; FLJ30410; Methenyl THF synthetase; Methenyl-THF synthetase; MTHFS_HUMAN; OTTHUMP00000185568;
NEDD4
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
NEDD4; neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase; RPF1; NEDD4-1; E3 ubiquitin-protein ligase NEDD4; receptor-potentiating factor 1; cell proliferation-inducing gene 53 protein; neural precursor cell expressed developmentally down-regulated protein 4;
PDCD1LG2
PDCD1LG2 programmed cell death 1 ligand 2
PDCD1LG2; programmed cell death 1 ligand 2; B7 dendritic cell molecule; B7 DC; bA574F11.2; Btdc; CD273; PD L2; PDL2; B7-DC; PD-1 ligand 2; PD-1-ligand 2; PDCD1 ligand 2; butyrophilin B7-DC; programmed death ligand 2; B7DC; PD-L2; PDCD1L2; MGC142238; MGC142240;
PPBP
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
Ppbp; PPBP; pro-platelet basic protein (chemokine (C-X-C motif) ligand 7); platelet basic protein; neutrophil activating peptide-2; chemokine (C-X-C motif) ligand 7; Cxcl7; Nap-2;
RBX1
ring-box 1, E3 ubiquitin protein ligase
RBX1; ring-box 1, E3 ubiquitin protein ligase; ROC1; RNF75; BA554C12.1; E3 ubiquitin-protein ligase RBX1; ZYP protein; RING box protein 1; RING-box protein 1; RING finger protein 75; regulator of cullins 1;
Selplg
selectin P ligand
SELPLG; selectin P ligand; CLA; CD162; PSGL1; PSGL-1; P-selectin glycoprotein ligand 1; cutaneous lymphocyte-associated associated antigen;
SKP2
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
SKP2; S-phase kinase-associated protein 2, E3 ubiquitin protein ligase; p45; FBL1; FLB1; FBXL1; S-phase kinase-associated protein 2; p45skp2; F-box/LRR-repeat protein 1; CDK2/cyclin A-associated protein p45; S-phase kinase-associated protein 2 (p45);
SMURF1
SMAD specific E3 ubiquitin protein ligase 1
SMURF1; SMAD specific E3 ubiquitin protein ligase 1; E3 ubiquitin-protein ligase SMURF1; KIAA1625; hSMURF1; E3 ubiquitin ligase SMURF1; Smad-specific E3 ubiquitin ligase 1; Smad ubiquitination regulatory factor 1; SMAD-specific E3 ubiquitin-protein ligase 1;
SMURF2
SMAD specific E3 ubiquitin protein ligase 2
SMURF2; SMAD specific E3 ubiquitin protein ligase 2; E3 ubiquitin-protein ligase SMURF2; hSMURF2; E3 ubiquitin ligase SMURF2; SMAD ubiquitination regulatory factor 2; SMAD-specific E3 ubiquitin-protein ligase 2; MGC138150; DKFZp686F0270;
STUB1
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
STUB1; STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase; CHIP; UBOX1; HSPABP2; NY-CO-7; SDCCAG7; E3 ubiquitin-protein ligase CHIP; antigen NY-CO-7; CLL-associated antigen KW-8; serologically defined colon cancer antigen 7; STIP1 homology and U box-containing protein 1; carboxy terminus of Hsp70-interacting protein; heat shock protein A binding protein 2 (c-terminal);
TNFSF10
tumor necrosis factor (ligand) superfamily, member 10
TNFSF10; tumor necrosis factor (ligand) superfamily, member 10; TL2; APO2L; CD253; TRAIL; Apo-2L; tumor necrosis factor ligand superfamily member 10; Apo-2 ligand; TNF-related apoptosis inducing ligand TRAIL; tumor necrosis factor (ligand) family, member 10; chemokine tumor necrosis factor ligand superfamily member 10; tumor necrosis factor apoptosis-inducing ligand splice variant delta;
Tnfsf11
tumor necrosis factor (ligand) superfamily, member 11
TNFSF11; tumor necrosis factor (ligand) superfamily, member 11; ODF; OPGL; sOdf; CD254; OPTB2; RANKL; TRANCE; hRANKL2; tumor necrosis factor ligand superfamily member 11; OTTHUMP00000018328; OTTHUMP00000178585; osteoprotegerin ligand; osteoclast differentiation factor; TNF-related activation-induced cytokine; receptor activator of nuclear factor kappa B ligand; receptor activator of nuclear factor kappa-B ligand;
TNFSF12
tumor necrosis factor (ligand) superfamily, member 12
TNFSF12; tumor necrosis factor (ligand) superfamily, member 12; APO3L; DR3LG; TWEAK;
TNFSF13
tumor necrosis factor (ligand) superfamily, member 13
TNFSF13; tumor necrosis factor (ligand) superfamily, member 13; tumor necrosis factor ligand superfamily member 13; APRIL; CD256; a proliferation-inducing ligand; tumor necrosis factor-like protein ZTNF2; tumor necrosis factor-related death ligand-1; TNF-;
TNFSF13B
tumor necrosis factor (ligand) superfamily, member 13b
DTL; BAFF; BLYS; CD257; TALL1; THANK; ZTNF4; TALL-1; TNFSF20; tumor necrosis factor ligand superfamily member 13B; delta BAFF; Delta4 BAFF; B-lymphocyte stimulator; B-cell-activating factor; ApoL related ligand TALL-1; TNF homolog that activates apoptosis; dendritic cell-derived TNF-like molecule; tumor necrosis factor-like protein ZTNF4; TNF and ApoL-related leukocyte expressed ligand 1; tumor necrosis factor (ligand) superfamily, member 20; tumor necrosis factor (ligand) superfamily, member 13b; tumor necrosis factor superfamily, member 13b; tumor necrosis factor superfamily, member 13b; TNFSF13B; CD257 antigen;
TNFSF14
tumor necrosis factor (ligand) superfamily, member 14
TNFSF14; tumor necrosis factor (ligand) superfamily, member 14; tumor necrosis factor ligand superfamily member 14; CD258; HVEM L; LIGHT; LTg; delta transmembrane LIGHT; herpesvirus entry mediator A; herpesvirus entry mediator ligand; herpesvirus entry mediator-ligand; herpes virus entry mediator ligand; ligand for herpesvirus entry mediator; tumor necrosis factor receptor-like 2; tumor necrosis factor superfamily member LIGHT; TR2; HVEML;
TNFSF15
tumor necrosis factor (ligand) superfamily, member 15
TNFSF15; tumor necrosis factor (ligand) superfamily, member 15; tumor necrosis factor ligand superfamily member 15; MGC129934; MGC129935; TL1; TL1A; TNF ligand related molecule 1; TNF superfamily ligand TL1A; vascular endothelial cell growth inhibitor; vascular endothelial growth inhibitor 192A; VEGI; VEGI192A; TNF ligand-related molecule 1; vascular endothelial growth inhibitor-192A;
TNFSF18
tumor necrosis factor (ligand) superfamily, member 18
TNFSF18; tumor necrosis factor (ligand) superfamily, member 18; Activation inducible TNF related ligand; Activation-inducible TNF-related ligand; AITRL; GITRL; Glucocorticoid induced TNF related ligand; Glucocorticoid induced TNFR related protein ligand; Glucocorticoid-induced TNF-related ligand; hGITRL; MGC138237; TL6; TNF18_HUMAN; Tumor necrosis factor (ligand) superfamily member 18; Tumor necrosis factor ligand superfamily member 18; GITR ligand; OTTMUSP00000033308; glucocorticoid-induced-tumor necrosis factor receptor ligand;
Tnfsf4
tumor necrosis factor (ligand) superfamily, member 4
TNFSF4; tumor necrosis factor (ligand) superfamily, member 4; tumor necrosis factor ligand superfamily member 4; OX40 ligand; atherosclerosis 1; tax-transcriptionally activated glycoprotein 1 ligand; Ath1; gp34; Ath-1; Ox40l; TXGP1; CD134L; OX-40L; Txgp1l; CD134L; CD 252; CD134; CD134 ligand; CD134L; CD252; CD252 antigen; glycoprotein 34 kd; glycoprotein Gp34; GP34; OX-40L; OX40 ligand; OX40L; TAX transcriptionally-activated glycoprotein 1; TNFL4; TNFSF4; tumor necrosis factor ligand superfamily member 4; TXGP1; tumor necrosis factor (ligand) superfamily, member 4;
TNFSF8
tumor necrosis factor (ligand) superfamily, member 8
TNFSF8; tumor necrosis factor (ligand) superfamily, member 8; CD30LG; tumor necrosis factor ligand superfamily member 8; CD153; CD30-L; CD30 ligand; CD153 antigen; CD30 antigen ligand; CD30L; MGC138144;
TNFSF9
Tnfsf9 tumor necrosis factor (ligand) superfamily, member 9
TNFSF9; tumor necrosis factor (ligand) superfamily, member 9; tumor necrosis factor ligand superfamily member 9; 4-1BB ligand; Ly63l; 4-1BBL; Cd137l; 4-1BB-L; AI848817;
Trim63
tripartite motif containing 63, E3 ubiquitin protein ligase
TRIM63; tripartite motif containing 63, E3 ubiquitin protein ligase; IRF; SMRZ; MURF1; MURF2; RNF28; E3 ubiquitin-protein ligase TRIM63; ring finger protein 28; iris ring finger protein; muscle specific ring finger protein 2; muscle-specific RING finger protein 1; tripartite motif-containing protein 63; striated muscle RING zinc finger protein;
VHL
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
VHL; von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase; von Hippel Lindau syndrome , von Hippel Lindau tumor suppressor; von Hippel-Lindau disease tumor suppressor; VHL1; protein G7; elongin binding protein; RCA1; pVHL; HRCA1;
WWP1
WW domain containing E3 ubiquitin protein ligase 1
WWP1; WW domain containing E3 ubiquitin protein ligase 1; AIP5; Tiul1; hSDRP1; NEDD4-like E3 ubiquitin-protein ligase WWP1; WW domain-containing protein 1; atrophin-1 interacting protein 5; atrophin-1-interacting protein 5; TGIF-interacting ubiquitin ligase 1; Nedd-4-like ubiquitin-protein ligase;
XCL1
chemokine (C motif) ligand 1
XCL1; chemokine (C motif) ligand 1; lymphotactin; lymphotaxin; cytokine SCM-1; c motif chemokine 1; small-inducible cytokine C1; small inducible cytokine subfamily C, member 1 (lymphotactin); LTN; ATAC; Lptn; SCM-1; Scyc1; SCM-1a; AI661682;
CHFR
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
CHFR; checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase; RNF116; RNF196; E3 ubiquitin-protein ligase CHFR; RING finger protein 196;
FBXW7
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
FBXW7; F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase; AGO; CDC4; FBW6; FBW7; hAgo; FBX30; FBXW6; SEL10; hCdc4; FBXO30; SEL-10; F-box/WD repeat-containing protein 7; archipelago; F-box protein FBW7; F-box protein FBX30; F-box protein SEL-10; homolog of C elegans sel-10; F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila);
GCLC
glutamate-cysteine ligase, catalytic subunit
GCLC; glutamate-cysteine ligase, catalytic subunit; GLCL, GLCLC; glutamate--cysteine ligase catalytic subunit; GCS; gamma-ECS; GCS heavy chain; gamma-glutamylcysteine synthetase; GCL; GLCL; GLCLC;
GCLM
glutamate-cysteine ligase, modifier subunit
GCLM; glutamate-cysteine ligase, modifier subunit; GLCLR; glutamate--cysteine ligase regulatory subunit; gamma glutamylcysteine synthetase; Gamma ECS regulatory subunit; Gamma-ECS regulatory subunit; Gamma-glutamylcysteine synthetase regulatory subunit; GCS light chain; Glutamate cysteine ligase regulatory subunit; Glutamate--cysteine ligase modifier subunit; GSH0_HUMAN; GSC light chain; OTTHUMP00000012299; glutamate-cysteine ligase regulatory protein; gamma-glutamylcysteine synthetase regula;
HECTD1
HECT domain containing E3 ubiquitin protein ligase 1
HECTD1; HECT domain containing E3 ubiquitin protein ligase 1; HECT domain containing 1; E3 ubiquitin-protein ligase HECTD1; KIAA1131; EULIR; E3 ligase for inhibin receptor; HECT domain-containing protein 1; FLJ38315;
HECW2
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2
HECW2; HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2; E3 ubiquitin-protein ligase HECW2; KIAA1301; NEDL2; E3 ubiquitin protein ligase HECW2; KIAA130; NEDD4 like E3 ubiquitin protein ligase 2; NEDD4 Related E3 Ubiquitin Ligase; NEDD4-related E3 ubiquitin ligase NEDL2; NEDD4-like E3 ubiquitin-protein ligase 2; HECT, C2 and WW domain-containing protein 2;
HERC3
HECT and RLD domain containing E3 ubiquitin protein ligase 3
HERC3; HECT and RLD domain containing E3 ubiquitin protein ligase 3; hect domain and RLD 3; probable E3 ubiquitin-protein ligase HERC3; KIAA0032; HECT domain and RCC1-like domain-containing protein 3;
LIG1
ligase I, DNA, ATP-dependent
LIG1; ligase I, DNA, ATP-dependent; DNA ligase 1; polydeoxyribonucleotide synthase [ATP] 1; MGC117397; MGC130025;
LIG4
ligase IV, DNA, ATP-dependent
LIG4; ligase IV, DNA, ATP-dependent; DNA ligase 4; sealase; DNA joinase; DNA ligase IV; DNA repair enzyme; polynucleotide ligase; polydeoxyribonucleotide synthase [ATP] 4;
LNX2
ligand of numb-protein X 2
LNX2; ligand of numb-protein X 2; PDZ domain containing ring finger 1 , PDZRN1; ligand of Numb protein X 2; MGC46315; FLJ12933; FLJ23932; FLJ38000; LNX 2; Numb binding protein 2; PDZ domain containing ring finger 1; PDZ domain containing RING finger protein 1; PDZRN 1; PDZRN1; OTTHUMP00000018170; numb-binding protein 2; PDZ domain-containing RING finger protein 1;
MARCH1
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase
MARCH1;membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase;26077;ENSG00000145416;RNF171;MARCH-I;4q32.2;FLJ20668, DKFZp564M1682;E3 ubiquitin-protein ligase MARCH1;E3 ubiquitin-protein ligase MARCH1;RING finger protein 171;membrane-associated RING-CH protein I;membrane-associated RING finger protein 1;
MARCH10
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase
MARCH10;membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase;26655;ENSG00000173838;RNF190;MARCH-X;17q23.2;FLJ35757;probable E3 ubiquitin-protein ligase MARCH10;probable E3 ubiquitin-protein ligase MARCH10;ring finger protein 190;membrane-associated RING-CH protein X;membrane-associated RING finger protein 10;
MARCH6
membrane-associated ring finger (C3HC4) 6, E3 ubiquitin protein ligase
MARCH6;membrane-associated ring finger (C3HC4) 6, E3 ubiquitin protein ligase;30550;ENSG00000145495;TEB4;DOA10;RNF176;MARCH-VI;5p15.2;KIAA0597, DKFZp586L081;E3 ubiquitin-protein ligase MARCH6;E3 ubiquitin-protein ligase MARCH6;doa10 homolog;RING finger protein 176;membrane-associated RING-CH protein VI;membrane-associated RING finger protein 6;membrane-associated RING-CH finger protein 6;EC 6.3.2.-;
MARCH7
membrane-associated ring finger (C3HC4) 7, E3 ubiquitin protein ligase
MARCH7;membrane-associated ring finger (C3HC4) 7, E3 ubiquitin protein ligase;17393;ENSG00000136536;AXO;AXOT;RNF177;MARCH-VII;2q24.2;DKFZp586F1122;E3 ubiquitin-protein ligase MARCH7;E3 ubiquitin-protein ligase MARCH7;axotrophin;RING finger protein 177;membrane-associated RING-CH protein VII;membrane-associated RING finger protein 7;EC 6.3.2.-;
P2RX5
purinergic receptor P2X, ligand-gated ion channel, 5
P2RX5; purinergic receptor P2X, ligand-gated ion channel, 5; P2X purinoceptor 5; P2X5; ATP receptor; ATP receptor subunit; ionotropic ATP receptor P2X5; MGC47755; P2X5R; Purinergic receptor; Purinergic receptor P2X ligand gated ion channel 5; OTTHUMP00000115870; OTTHUMP00000241718; OTTHUMP00000241719; OTTHUMP00000241720; OTTHUMP00000241722; OTTHUMP00000241723; lymphoid-restricted histocompatibility antigen-1; LRH-1;
PARK2
parkinson protein 2, E3 ubiquitin protein ligase (parkin)
PARK2; PDJ; PRKN; AR-JP; LPRS2; parkin; parkinson protein 2, E3 ubiquitin protein ligase (parkin); E3 ubiquitin-protein ligase parkin; parkin 2; OTTHUMP00000017562; OTTHUMP00000017563; OTTHUMP00000017564; OTTHUMP00000017565; OTTHUMP00000017566; OTTHUMP00000017567; E3 ubiquitin ligase; parkinson disease protein 2; parkinson juvenile disease protein 2; Parkinson disease (autosomal recessive, juvenile) 2, parkin; EC 6.3.2.-;
RCHY1
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase
RCHY1; ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase; ring finger and CHY zinc finger domain containing 1 , zinc finger protein 363 , ZNF363; RING finger and CHY zinc finger domain-containing protein 1; androgen recepto;
RFFL
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase
RFFL; ring finger and FYVE-like domain containing E3 ubiquitin protein ligase; ring finger and FYVE like domain containing; E3 ubiquitin-protein ligase rififylin; fring; rififylin; RNF34L; RNF189; RING finger protein 189; caspase regulator CARP2; FYVE-RIN;
RNF125
ring finger protein 125, E3 ubiquitin protein ligase
RNF125; ring finger protein 125, E3 ubiquitin protein ligase; ring finger protein 125; E3 ubiquitin-protein ligase RNF125; FLJ20456; T-cell RING activation protein 1; T-cell ring protein identified in activation screen; TRAC1; TRAC-1; MGC21737;
RNF168
ring finger protein 168, E3 ubiquitin protein ligase
RNF168; ring finger protein 168, E3 ubiquitin protein ligase; ring finger protein 168; E3 ubiquitin-protein ligase RNF168; FLJ35794; FLJ39749;
RNF20
ring finger protein 20, E3 ubiquitin protein ligase
RNF20; ring finger protein 20, E3 ubiquitin protein ligase; BRE1; BRE1A; hBRE1; E3 ubiquitin-protein ligase BRE1A; BRE1-A; homolog of S. cerevisiae BRE1; BRE1 E3 ubiquitin ligase homolog;
RNF40
ring finger protein 40, E3 ubiquitin protein ligase
RNF40; ring finger protein 40, E3 ubiquitin protein ligase; BRE1B; RBP95; STARING; E3 ubiquitin-protein ligase BRE1B; BRE1-B; Rb-associated protein; BRE1 E3 ubiquitin ligase homolog B; 95 kDa retinoblastoma-associated protein; 95 kDa retinoblastoma protein binding protein;
RNF8
ring finger protein 8, E3 ubiquitin protein ligase
RNF8; ring finger protein 8, E3 ubiquitin protein ligase; hRNF8; E3 ubiquitin-protein ligase RNF8; C3HC4-type zinc finger protein; ring finger protein (C3HC4 type) 8; UBC13/UEV-interacting ring finger protein;
TOPORS
topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase
TOPORS; topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase; retinitis pigmentosa 31 (autosomal dominant) , RP31, topoisomerase I binding, arginine/serine rich; E3 ubiquitin-protein ligase Topors; LUN; TP53BPL; SUMO1-protein E3 lig;
TRAF6
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase; RNF85; MGC:3310; TNF receptor-associated factor 6; RING finger protein 85; interleukin-1 signal transducer; E3 ubiquitin-protein ligase TRAF6;
UBE3A
ubiquitin protein ligase E3A
UBE3A; ubiquitin protein ligase E3A; EPVE6AP, HPVE6A, human papilloma virus E6 associated protein; ubiquitin-protein ligase E3A; ANCR; Angelman syndrome; AS; E6 AP; FLJ26981; CTCL tumor antigen se37-2; E6AP ubiquitin-protein ligase; renal carcinoma antig; E6-AP; HPVE6A; EPVE6AP;
UBR1
ubiquitin protein ligase E3 component n-recognin 1
UBR1; ubiquitin protein ligase E3 component n-recognin 1; JBS; E3 ubiquitin-protein ligase UBR1; E3a ligase; N-recognin-1; ubiquitin ligase E3 alpha-I; ubiquitin-protein ligase E3-alpha; ubiquitin-protein ligase E3-alpha-1; ubiquitin-protein ligase E3-alpha-I;
UBR2
Ubiquitin protein ligase E3 component n-recognin 2
UBR2;Ubiquitin protein ligase E3 component n-recognin 2;Rabbit;Human;Rabbit Anti-Human UBR2 Polyclonal Antibody;Rabbit Anti-Human UBR2;Polyclonal Antibody;Rabbit Anti-Human UBR2 Antibody;Polyclonal;Rabbit Anti-Human UBR2 Polyclonal;Antibody;Rabbit Anti-Human Ubiquitin protein ligase E3 component n-recognin 2 Polyclonal;Rabbit Anti-Human Ubiquitin protein ligase E3 component n-recognin 2 Antibody;Anti-Human UBR2 Polyclonal;Anti-Human UBR2 Antibody;Anti-Human Ubiquitin protein ligase E3 component n-recognin 2 Polyclonal;Anti-Human Ubiquitin protein ligase E3 component n-recognin 2 Antibody;Anti-Human UBR2;Anti-UBR2;Anti-Human Ubiquitin protein ligase E3 component n-recognin 2;Anti-Ubiquitin protein ligase E3 component n-recognin 2;
UBR3
ubiquitin protein ligase E3 component n-recognin 3 (putative)
UBR3; ubiquitin protein ligase E3 component n-recognin 3 (putative); zinc finger protein 650 , ZNF650; E3 ubiquitin-protein ligase UBR3; DKFZp434P117; FLJ37422; KIAA2024; DKFZp686N10185; MGC126489; Zinc finger protein 650; ZNF 650; N-recognin-3; OTTHUMP00000163072; ubiquitin-protein ligase E3-alpha-3; ubiquitin-protein ligase E3-alpha-III; ZNF650;
UBR4
ubiquitin protein ligase E3 component n-recognin 4
UBR4; ubiquitin protein ligase E3 component n-recognin 4; zinc finger, UBR1 type 1 , ZUBR1; E3 ubiquitin-protein ligase UBR4; KIAA0462; KIAA1307; RBAF600; 600 kDa retinoblastoma protein associated factor; 600 kDa retinoblastoma protein-associated factor; N-recognin-4; p600; Retinoblastoma associated factor 600 like protein; Retinoblastoma associated factor of 600 kDa; Retinoblastoma-associated factor 600; Retinoblastoma-associated factor of 600 kDa; Ubiquitin protein ligase E3 component n recognin 4; UBR4_HUMAN; Zinc finger UBR1 type protein 1; Zinc finger UBR1-type protein 1; Zinc finger, UBR1 type 1; ZUBR 1; ZUBR1; OTTHUMP00000002585; retinoblastoma-associated factor 600-like protein; RP5-1126H10.1;
CCNB1IP1
cyclin B1 interacting protein 1, E3 ubiquitin protein ligase
CCNB1IP1; cyclin B1 interacting protein 1, E3 ubiquitin protein ligase; C14orf18, chromosome 14 open reading frame 18 , cyclin B1 interacting protein 1; E3 ubiquitin-protein ligase CCNB1IP1; HEI10; human enhancer of invasion 10; C14orf18; Chromosome 14 open reading frame 18; CIP1_HUMAN; Cyclin B1 interacting protein 1; Cyclin-B1-interacting protein 1; Enhancer of invasion 10; OTTHUMP00000163984; OTTHUMP00000163985; OTTHUMP00000163986; OTTHUMP00000244397;
SHPRH
SNF2 histone linker PHD RING helicase, E3 ubiquitin protein ligase
SHPRH; SNF2 histone linker PHD RING helicase, E3 ubiquitin protein ligase; bA545I5.2; E3 ubiquitin-protein ligase SHPRH; 2610103K11Rik; SNF2, histone-linker, PHD and RING finger domain-containing helicase;
BTRC
beta-transducin repeat containing E3 ubiquitin protein ligase
BTRC; beta-transducin repeat containing E3 ubiquitin protein ligase; beta transducin repeat containing; F-box/WD repeat-containing protein 1A; beta TrCP1; betaTrCP; bTrCP; bTrCP1; FBXW1A; Fwd1; beta-TrCP1; E3RSIkappaB; F-box and WD-repeat protein 1B; pIka;
AMFR
autocrine motility factor receptor, E3 ubiquitin protein ligase
AMFR; autocrine motility factor receptor, E3 ubiquitin protein ligase; autocrine motility factor receptor; gp78; RNF45; RING finger protein 45;
CBLC
Cbl proto-oncogene, E3 ubiquitin protein ligase C
CBLC; Cbl proto-oncogene, E3 ubiquitin protein ligase C; Cas Br M (murine) ecotropic retroviral transforming sequence c , Cas Br M (murine) ectropic retroviral transforming sequence c; signal transduction protein CBL-C; CBL 3; CBL SL; RNF57; RING finger;
CCL4L2
chemokine (C-C motif) ligand 4-like 2
CCL4L2; chemokine (C-C motif) ligand 4-like 2; CC chemokine ligand 4L2; CC chemokine ligand 4L1d2; lymphocyte activation gene 1; macrophage inflammatory protein-1b2; chemokine (C-C motif) ligand 4-like 1, telomeric; CCL4L; SCYA4L; AT744.2;
LIG3
ligase III, DNA, ATP-dependent
LIG3; ligase III, DNA, ATP-dependent; LIG2, ligase II, DNA, ATP dependent; DNA ligase 3; ligase II, DNA, ATP-dependent; polydeoxyribonucleotide synthase [ATP] 3; LIG2;
LNX1
ligand of numb-protein X 1, E3 ubiquitin protein ligase
LNX1; ligand of numb-protein X 1, E3 ubiquitin protein ligase; ligand of numb protein X , ligand of numb protein X 1 , LNX; E3 ubiquitin-protein ligase LNX; MPDZ; PDZRN2; numb-binding protein 1; PDZ domain-containing ring finger protein 2; multi-PDZ-doma;
MARCH2
membrane-associated ring finger (C3HC4) 2, E3 ubiquitin protein ligase
MARCH2;membrane-associated ring finger (C3HC4) 2, E3 ubiquitin protein ligase;28038;ENSG00000099785;RNF172;HSPC240;MARCH-II;19p13.2;E3 ubiquitin-protein ligase MARCH2;E3 ubiquitin-protein ligase MARCH2;RING finger protein 172;membrane-associated RING-CH protein II;membrane-associated RING finger protein 2;EC 6.3.2.-;
MARCH3
membrane-associated ring finger (C3HC4) 3, E3 ubiquitin protein ligase
MARCH3;membrane-associated ring finger (C3HC4) 3, E3 ubiquitin protein ligase;28728;ENSG00000173926;RNF173;MARCH-III;5q23.2;FLJ20096, MGC48332;E3 ubiquitin-protein ligase MARCH3;E3 ubiquitin-protein ligase MARCH3;RING finger protein 173;membrane-associated RING-CH protein III;membrane-associated RING finger protein 3;
MIB1
mindbomb E3 ubiquitin protein ligase 1
MIB1; mindbomb E3 ubiquitin protein ligase 1; mindbomb homolog 1 (Drosophila); E3 ubiquitin-protein ligase MIB1; DIP 1; KIAA1323; MIB; ZZANK2; ZZZ6; mindbomb homolog 1; mind bomb homolog 1; DAPK-interacting protein 1; ubiquitin ligase mind bomb; ubiquitin ligase protein MIB1; zinc finger ZZ type with ankyrin repeat domain protein 2; DIP-1; FLJ90676; MGC129659; MGC129660; DKFZp686I0769; DKFZp761M1710;
NAV2
neuron navigator 2
NAV2; neuron navigator 2; FLJ10633; FLJ11030; FLJ23707; HELAD1; helicase; APC down regulated 1; KIAA1419; POMFIL2; pore membrane and/or filament interacting like protein 2; RAINB1; retinoic acid inducible gene in neuroblastoma 1; 5330421F07Rik; AU067780; mKIAA3015; RAINB2; Helicase, APC down regulated 1; mCG 145366; NAV 2; Retinoic acid inducible in neuroblastoma 1; Steerin 2; STEERIN2; Unc 53 homolog 2; Unc53H2; steerin-2; unc-53 homolog 2; helicase, APC down-regulated 1; pore membrane and/or filament-interacting-like protein 2;
NEDD4L
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
NEDD4L; neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase; neural precursor cell expressed, developmentally down regulated 4 like; E3 ubiquitin-protein ligase NEDD4-like; KIAA0439; NEDD4 2; RSP5; ubiquitin;
RNF138
ring finger protein 138, E3 ubiquitin protein ligase
RNF138; ring finger protein 138, E3 ubiquitin protein ligase; ring finger protein 138; E3 ubiquitin-protein ligase RNF138; STRIN; NLK-associated RING finger protein; Nemo-like kinase-associated RING finger protein; NARF; HSD-4; hNARF; MGC8758;
SIAH2
siah E3 ubiquitin protein ligase 2
SIAH2; siah E3 ubiquitin protein ligase 2; hSiah2; E3 ubiquitin-protein ligase SIAH2; siah-2; seven in absentia homolog 2;
TTLL1
tubulin tyrosine ligase-like family, member 1
TTLL1; tubulin tyrosine ligase-like family, member 1; C22orf7, tubulin tyrosine ligase like 1; probable tubulin polyglutamylase TTLL1; C22orf7; Catalytic subunit of neural tubulin polyglutamylase; HS323M22B; OTTHUMP00000028544; PGs3; TTLL 1; Tubulin polyglutamylase complex subunit 3; Tubulin tyrosine ligase; Tubulin tyrosine ligase like 1; Tubulin tyrosine ligase like family member 1; Tubulin tyrosine ligase like protein 1; tubulin-tyrosine ligase; tubulin--tyrosine ligase-like protein 1;
UHRF2
ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase
UHRF2; ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase; ubiquitin like with PHD and ring finger domains 2; E3 ubiquitin-protein ligase UHRF2; MGC33463; NIRF; Np95 like ring finger protein; RNF107; URF2; nuclear protein 97; R;
ZNRF1
zinc and ring finger 1, E3 ubiquitin protein ligase
ZNRF1; zinc and ring finger 1, E3 ubiquitin protein ligase; zinc and ring finger 1; E3 ubiquitin-protein ligase ZNRF1; DKFZp434E229; FLJ14846; nin283; nerve injury gene 283; zinc/RING finger protein 1; zinc and ring finger protein 1; nerve injury-induced;
Ccl21a
chemokine (C-C motif) ligand 21A (serine)
Ccl21a; chemokine (C-C motif) ligand 21A (serine); ALP; SLC; plt; CKb9; Tca4; 6Ckine; Scya21; 6CKBAC2; SCYA21a; Scya21b; AW987545;
CCL4L1
chemokine (C-C motif) ligand 4-like 1
CCL4L1;chemokine (C-C motif) ligand 4-like 1;CCL4L, chemokine (C C motif) ligand 4 like, SCYA4L, small inducible cytokine A4 like;C-C motif chemokine 4-like;AT744.2;LAG 1;MIP-1-beta;macrophage inflammatory protein-1b2;lymphocyte activation gene 1 protein;macrophage inflammatory protein 1-beta;monocyte adherence-induced protein 5-alpha;LAG1;CCL4L;LAG-1;SCYA4L;
Flt3l
FMS-like tyrosine kinase 3 ligand
Flt3l; FMS-like tyrosine kinase 3 ligand; Ly72L; Flt3lg; fms-related tyrosine kinase 3 ligand; flt3 ligand;
HACE1
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
HACE1; HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1; E3 ubiquitin-protein ligase HACE1; KIAA1320; HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1; HECT domain and ankyrin repeat containing, E3 ubiquitin p;
HECTD2
HECT domain containing E3 ubiquitin protein ligase 2
HECTD2; HECT domain containing E3 ubiquitin protein ligase 2; HECT domain containing 2; probable E3 ubiquitin-protein ligase HECTD2; FLJ37306; HECT domain-containing protein 2; FLJ16050;
CBLB
Cbl proto-oncogene, E3 ubiquitin protein ligase B
CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B; Cas Br M (murine) ecotropic retroviral transforming sequence b , Cas Br M (murine) ectropic retroviral transforming sequence b; E3 ubiquitin-protein ligase CBL-B; Cbl b; RNF56; RING finger protein;
P2RX7
P2rx7 purinergic receptor P2X, ligand-gated ion channel, 7
P2RX7; purinergic receptor P2X, ligand-gated ion channel, 7; P2X purinoceptor 7; ATP receptor; P2Z receptor; P2X7 purinoceptor; purinergic receptor P2X7;
CCL3L3
chemokine (C-C motif) ligand 3-like 3
CCL3L3;chemokine (C-C motif) ligand 3-like 3;C-C motif chemokine 3-like 1;MGC12815;G0S19-2;PAT 464.2;LD78-beta(1-70);small inducible cytokine A3-like 1;G0/G1 switch regulatory protein 19-2;tonsillar lymphocyte LD78 beta protein;chemokine (C-C motif) ligand 3-like, centromeric;LD78;464.2;SCYA3L;SCYA3L1;D17S1718;LD78BETA;
MARCH8
membrane-associated ring finger (C3HC4) 8, E3 ubiquitin protein ligase
MARCH8;membrane-associated ring finger (C3HC4) 8, E3 ubiquitin protein ligase;23356;ENSG00000165406;MIR;c-MIR;RNF178;MARCH-VIII;10q11.21;E3 ubiquitin-protein ligase MARCH8;E3 ubiquitin-protein ligase MARCH8;RING finger protein 178;membrane-associated RING-CH protein VIII;membrane-associated RING finger protein 8;c-mir, cellular modulator of immune recognition;cellular modulator of immune recognition (c-MIR);
P2RX3
purinergic receptor P2X, ligand-gated ion channel, 3
P2RX3; purinergic receptor P2X, ligand-gated ion channel, 3; P2X3; P2X purinoceptor 3; ATP receptor; purinoceptor P2X3; P2X receptor, subunit 3; purinergic receptor P2X3;
MARCH4
membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase
MARCH4;membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase;29269;ENSG00000144583;RNF174;MARCH-IV;2q35;MGC104908;E3 ubiquitin-protein ligase MARCH4;E3 ubiquitin-protein ligase MARCH4;RING finger protein 174;membrane-associated RING-CH protein IV;membrane-associated RING finger protein 4;
RNF34
ring finger protein 34, E3 ubiquitin protein ligase
RNF34; ring finger protein 34, E3 ubiquitin protein ligase; ring finger protein 34; E3 ubiquitin-protein ligase RNF34; FLJ21786; RIF; RIFF; caspase regulator CARP1; RING finger protein RIFF; FYVE-RING finger protein MOMO; caspases-8 and -10-associated RIN;
birA
biotin ligase
birA; biotin ligase; Bifunctional protein birA; Bio R; BioR; Biotin [acetyl CoA carboxylase] synthetase; Biotin operon repressor; Biotin protein ligase; Bir A; BirA bifunctional protein; Dhb B; dhbB; biotin--protein ligase;
UBR7
ubiquitin protein ligase E3 component n-recognin 7 (putative)
UBR7; ubiquitin protein ligase E3 component n-recognin 7 (putative); C14orf130, chromosome 14 open reading frame 130; putative E3 ubiquitin-protein ligase UBR7; 5730410I19Rik; AA589405; AW557761; Chromosome 14 open reading frame 130; EC 6.3.2.-; FLJ10483; MGC94098; MGC9518; N recognin 7; RGD1359144; N-recognin-7; C14orf130;
LRIF1
ligand dependent nuclear receptor interacting factor 1
LRIF1; ligand dependent nuclear receptor interacting factor 1; C1orf103, chromosome 1 open reading frame 103; ligand-dependent nuclear receptor-interacting factor 1; FLJ11269; receptor interacting factor 1; RIF1; Chromosome 1 open reading frame 103; RP11 96K19.1; Uncharacterized protein C1orf103; receptor-interacting factor 1; C1orf103; RP11-96K19.1;
UBR5
ubiquitin protein ligase E3 component n-recognin 5
UBR5; ubiquitin protein ligase E3 component n-recognin 5; E3 ubiquitin protein ligase, HECT domain containing, 1 , EDD1; E3 ubiquitin-protein ligase UBR5; DD5; EDD; HYD; KIAA0896; hHYD; ubiquitin-protein ligase; progestin induced protein; progestin-induce;
MUL1
mitochondrial E3 ubiquitin protein ligase 1
MUL1; mitochondrial E3 ubiquitin protein ligase 1; C1orf166, chromosome 1 open reading frame 166; mitochondrial ubiquitin ligase activator of NFKB 1; FLJ12875; GIDE; growth inhibition and death E3 ligase; MAPL; mitochondria anchored protein ligase; MULAN; ring finger protein 218; RNF218; 0610009K11Rik; AV000801; RGD1309944; RP11-401M16.2; C1orf166; E3 ubiquitin ligase; E3 ubiquitin protein ligase MUL1; Mitochondrial anchored protein ligase; Putative NF kappa B activating protein 266; RP23-25C1.10-002; E3 ubiquitin-protein ligase MUL1; mitochondrial E3 ubiquitin ligase 1; mitochondria-anchored protein ligase; mitochondrial-anchored protein ligase; putative NF-kappa-B-activating protein 266; mitochondrial ubiquitin ligase activator of NF-kB;
G2E3
G2/M-phase specific E3 ubiquitin protein ligase
G2E3; G2/M-phase specific E3 ubiquitin protein ligase; KIAA1333; G2/M phase-specific E3 ubiquitin-protein ligase; FLJ20333; PHD finger protein 7B; PHF7B; G2/M phase specific E3 ubiquitin protein ligase; G2/M-phase specific E3 ubiquitin ligase;
HLCS
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase)
HLCS; holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase); holocarboxylase synthetase (biotin (proprionyl Coenzyme A carboxylase (ATP hydrolysing)) ligase) , holocarboxylase synthetase (biotin [proprionyl Coenzyme A carboxylase (ATP hydrolysing)] ligase); biotin--protein ligase; HCS; Biotin [acetyl CoA carboxylase] ligase; Biotin [methylcrotonoyl CoA carboxylase] ligase; Biotin [methylmalonyl CoA carboxytransferase] ligase; Biotin [propionyl CoA carboxylase [ATP hydrolyzing]] ligase; Biotin apo protein ligase; Biotin apo-protein ligase; Biotin protein ligase; Biotin--[acetyl-CoA-carboxylase] ligase; BPL1_HUMAN; EC 6.3.4.-; Holocarboxylase synthetase; Holocarboxylase synthetase, EC 6.3.4; biotin--[methylcrotonoyl-CoA-carboxylase] ligase; biotin--[methylmalonyl-CoA-carboxytransferase] ligase; holocarboxylase synthetase (biotin-(proprionyl-Coenzyme A-carboxylase (ATP-hydrolysing)) ligase);
HERC6
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
HERC6; HECT and RLD domain containing E3 ubiquitin protein ligase family member 6; hect domain and RLD 6; probable E3 ubiquitin-protein ligase HERC6; FLJ20637; potential ubiquitin ligase; HECT domain and RCC1-like domain-containing protein 6;
ZACN
zinc activated ligand-gated ion channel
ZACN; zinc activated ligand-gated ion channel; LGICZ1, ligand gated ion channel, zinc activated 1; zinc-activated ligand-gated ion channel; L2; LGICZ; ZAC; ZAC1; Ligand gated ion channel receptor L2; Ligand gated ion channel zinc activated 1; Zinc activated ligand gated ion channel; ligand-gated ion channel subunit; ligand-gated ion-channel receptor L2; ligand-gated ion channel zinc-activated 1; zinc activated ligand-gated ion channel 1; ligand-gated ion channel, zinc activated 1; LGICZ1;
UFL1
UFM1-specific ligase 1
UFL1; UFM1-specific ligase 1; KIAA0776; E3 UFM1-protein ligase 1; Maxer; NLBP; novel LZAP binding protein; RCAD; Regulator of CDK5RAP3 and DDRGK1; LZAP-binding protein; novel LZAP-binding protein; RP3-393D12.1;
NAV3
neuron navigator 3
NAV3; neuron navigator 3; KIAA0938; POMFIL1; pore membrane and/or filament interacting like protein 1; steerin 3; steerin-3; unc-53 homolog 3; pore membrane and/or filament-interacting-like protein 1; unc53H3; STEERIN3;
LCOR
ligand dependent nuclear receptor corepressor
LCOR; ligand dependent nuclear receptor corepressor; ligand-dependent corepressor; FLJ38026; KIAA1795; MLR2; A630025C20RIK; LCOR_HUMAN; Ligand dependent corepressor; Mblk1 related protein 2; Mblk1-related protein 2; RP11 175O19.1;
LCORL
ligand dependent nuclear receptor corepressor-like
LCORL; ligand dependent nuclear receptor corepressor-like; ligand-dependent nuclear receptor corepressor-like protein; Transcription factor MLR1; LCoR-like protein; LCORL_HUMAN; ligand dependent nuclear receptor corepressor like; MLR1; Mblk1-related protein-1; mblk1-related protein 1;
MYCBP2
MYC binding protein 2, E3 ubiquitin protein ligase
MYCBP2; MYC binding protein 2, E3 ubiquitin protein ligase; MYC binding protein 2; probable E3 ubiquitin-protein ligase MYCBP2; FLJ10106; KIAA0916; PAM; myc-binding protein 2; pam/highwire/rpm-1 protein; protein associated with Myc; FLJ13826; FLJ21597; FL;
P2RX1
purinergic receptor P2X, ligand-gated ion channel, 1
P2RX1; purinergic receptor P2X, ligand-gated ion channel, 1; P2X1; P2X purinoceptor 1; ATP receptor; P2X1 receptor; P2X receptor, subunit 1; purinergic receptor P2X1;
NAV1
neuron navigator 1
NAV1; neuron navigator 1; POMFIL3; UNC53H1; STEERIN1; unc-53 homolog 1; neuron navigator-1; pore membrane and/or filament interacting like protein 3; pore membrane and/or filament-interacting-like protein 3;
P2RX2
purinergic receptor P2X, ligand-gated ion channel, 2
P2RX2; purinergic receptor P2X, ligand-gated ion channel, 2; P2X2; DFNA41; P2X purinoceptor 2; ATP receptor; P2X Receptor, subunit 2;
P2RX4
purinergic receptor P2X, ligand-gated ion channel, 4
P2RX4; purinergic receptor P2X, ligand-gated ion channel, 4; P2X4; P2X4R; P2X purinoceptor 4; ATP receptor; purinoceptor P2X4; P2X receptor, subunit 4; purinergic receptor P2X4; ATP-gated cation channel protein;
P2RX6
purinergic receptor P2X, ligand-gated ion channel, 6
P2RX6; purinergic receptor P2X, ligand-gated ion channel, 6; P2RXL1, purinergic receptor P2X like 1, orphan receptor; P2X purinoceptor 6; MGC129625; P2X6; P2XM; ATP receptor; P2RXL1; Purinergic receptor; Purinergic receptor P2X like 1; Skeletal muscle expressed P2X; purinoceptor P2X6; purinoreceptor P2X6; skeletal muscle-expressed P2X; purinergic receptor P2X-like 1, orphan receptor;
LTN1
listerin E3 ubiquitin protein ligase 1
LTN1; listerin E3 ubiquitin protein ligase 1; C21orf10, C21orf98, chromosome 21 open reading frame 98 , ring finger protein 160 , RNF160, zinc finger protein 294 , ZNF294; E3 ubiquitin-protein ligase listerin; FLJ11053; KIAA0714; LISTERIN; ri;
SUCLG2
succinate-CoA ligase, GDP-forming, beta subunit
SUCLG2; succinate-CoA ligase, GDP-forming, beta subunit; succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial; EC 6.2.1.4; G BETA; GBETA; GTP specific succinyl-CoA synthetase beta subunit; GTP specific succinyl-CoA synthetase subunit beta; SCS betaG; Succinate CoA ligase GDP forming beta subunit; Succinate-Coenzyme A ligase, GDP-forming, beta subunit; Succinyl CoA ligase GDP forming beta chain mitochondrial; Succinyl CoA synthetase betaG chain; Succinyl-CoA synthetase beta-G chain; SCS-betaG; OTTHUMP00000213363; OTTHUMP00000213364; OTTHUMP00000213365; succinyl-CoA synthetase, beta-G chain; GTP-specific succinyl-CoA synthetase beta subunit; GTP-specific succinyl-CoA synthetase subunit beta; succinyl-CoA ligase, GDP-forming, beta chain, mitochondrial;
TTLL9
tubulin tyrosine ligase-like family, member 9
TTLL9; tubulin tyrosine ligase-like family, member 9; C20orf125, chromosome 20 open reading frame 125; probable tubulin polyglutamylase TTLL9; dJ310O13.1; tubulin--tyrosine ligase-like protein 9; C20orf125; MGC120486; MGC120487;
UBE3B
ubiquitin protein ligase E3B
UBE3B; ubiquitin protein ligase E3B; ubiquitin-protein ligase E3B; MGC131858; MGC78388; AI449831; AU020130; FLJ45294; OTTHUMP00000240552; OTTHUMP00000240554; OTTHUMP00000240555; OTTHUMP00000240558;
WWP2
WW domain containing E3 ubiquitin protein ligase 2
WWP2; WW domain containing E3 ubiquitin protein ligase 2; NEDD4-like E3 ubiquitin-protein ligase WWP2; AIP2; Atrophin 1 interacting protein 2; NEDD4 like E3 ubiquitin protein ligase; WW domain-containing protein 2; Wwp 2; atrophin-1 interacting protein 2; atrophin-1-interacting protein 2; Nedd-4-like ubiquitin-protein ligase; WWp2-like;
UBE3C
ubiquitin protein ligase E3C
UBE3C; ubiquitin protein ligase E3C; ubiquitin-protein ligase E3C; KIAA10; KIAA0010; Ubiquitin protein isopeptide ligase (E3); OTTHUMP00000211811; ubiquitin-protein isopeptide ligase (E3);
TTLL10
tubulin tyrosine ligase-like family, member 10
TTLL10; tubulin tyrosine ligase-like family, member 10; TTLL5, tubulin tyrosine ligase like family, member 5; inactive polyglycylase TTLL10; FLJ36119; tubulin--tyrosine ligase-like protein 10; tubulin tyrosine ligase-like family, member 5; TTLL5; RP5-902;
TTLL3
tubulin tyrosine ligase-like family, member 3
TTLL3; tubulin tyrosine ligase-like family, member 3; tubulin monoglycylase TTLL3; DKFZP434B103; HOTTL; PRO0207; Tubulin tyrosine ligase like protein 3; tubulin--tyrosine ligase-like protein 3;
TTLL6
tubulin tyrosine ligase-like family, member 6
TTLL6; tubulin tyrosine ligase-like family, member 6; tubulin polyglutamylase TTLL6; FLJ35808; TTL 6; TTL.6; Tubulin tyrosine ligase like family, member 6; tubulin--tyrosine ligase-like protein 6;
TRIM71
tripartite motif containing 71, E3 ubiquitin protein ligase
TRIM71; tripartite motif containing 71, E3 ubiquitin protein ligase; tripartite motif containing 71 , tripartite motif containing 71; tripartite motif-containing protein 71; LIN 41; LIN41; protein lin-41 homolog; abnormal cell LINeage LIN-41; homolog of;
Cxcl17
chemokine (C-X-C motif) ligand 17
CXCL17;chemokine (C-X-C motif) ligand 17;VEGF co-regulated chemokine 1;Dcip1;DMC;UNQ473;VCC1;C-X-C motif chemokine 17;dendritic cell and monocyte chemokine-like protein;VCC-1;MGC138300;
Fcamr
Fc receptor, IgA, IgM, high affinity
FCAMR;Fc receptor, IgA, IgM, high affinity;ENSMUSG00000026415;1;1 F;MGC129330, MGC129331;high affinity immunoglobulin alpha and immunoglobulin mu Fc receptor;high affinity immunoglobulin alpha and immunoglobulin mu Fc receptor;mFcamR;Fca/m receptor;Fc IgA/IgM receptor;fc alpha/mu receptor;
HECW1
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
HECW1;HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1;22195;ENSG00000002746;NEDL1;7p13;KIAA0322;E3 ubiquitin-protein ligase HECW1;E3 ubiquitin-protein ligase HECW1;HECT type E3 ubiquitin ligase;NEDD4-like ubiquitin-protein ligase 1;NEDD4-like E3 ubiquitin-protein ligase 1;HECT, C2 and WW domain-containing protein 1;
TTLL2
tubulin tyrosine ligase-like family, member 2
TTLL2;tubulin tyrosine ligase-like family, member 2;21211;ENSG00000120440;C6orf104;NYD-TSPG;dJ366N23.3;6q27;probable tubulin polyglutamylase TTLL2;probable tubulin polyglutamylase TTLL2;testis-specific protein NYD-TSPG;tubulin--tyrosine ligase-like protein 2;
TTLL4
tubulin tyrosine ligase-like family, member 4
TTLL4;tubulin tyrosine ligase-like family, member 4;28976;ENSG00000135912;2p24.3-p24.1;KIAA0173;tubulin polyglutamylase TTLL4;tubulin polyglutamylase TTLL4;tubulin--tyrosine ligase-like protein 4;
UBE3D
ubiquitin protein ligase E3D
UBE3D;ubiquitin protein ligase E3D;21381;ENSG00000118420;H10BH;UBE2CBP;YJR141W;C6orf157;6q14.1;MGC126561, MGC126587, DKFZp434A1520;E3 ubiquitin-protein ligase E3D;E3 ubiquitin-protein ligase E3D;UBCH10 binding protein with a hect-like domain;ubcH10-binding protein with a HECT-like domain;ubiquitin-conjugating enzyme E2C binding protein;ubiquitin-conjugating enzyme E2C-binding protein;EC 6.3.2.-;
PELI1
pellino E3 ubiquitin protein ligase 1
PELI1;pellino E3 ubiquitin protein ligase 1;8827;ENSG00000197329;2p13.3;MGC50990, DKFZp686C18116;E3 ubiquitin-protein ligase pellino homolog 1;E3 ubiquitin-protein ligase pellino homolog 1;pellino-1;pellino homolog 1;protein pellino homolog 1;pellino-related intracellular-signaling molecule;
Ccl21b
chemokine (C-C motif) ligand 21B (leucine)
SLC; CKb9; TCA4; 6Ckine; Scya21; 6CKBAC1; Scya21a; AI159701;
4933421E11Rik
ligand dependent nuclear receptor interacting factor 1
Rif1; AI450568; 2010012G17Rik; 4933421E11Rik;
Rnf5
ring finger protein 5, E3 ubiquitin protein ligase
RNF5; RMA1; RING5; ring finger protein 5, E3 ubiquitin protein ligase; E3 ubiquitin-protein ligase RNF5; protein G16; ram1 homolog;
BAFF
tumor necrosis factor (ligand) superfamily, member 13b
BAFF; BLyS; TALL1; THANK; zTNF4; TALL-1; TNFSF20; D8Ertd387e;
HECTD4
HECTD4 HECT domain containing E3 ubiquitin protein ligase 4 [ Homo sapiens (human) ]
probable E3 ubiquitin-protein ligase HECTD4; transmembrane protein C12orf51; HECT domain-containing protein 4; AF-1 specific protein phosphatase; probable E3 ubiquitin-protein ligase C12orf51; C12orf51; DKFZp586O1022; FLJ10510; FLJ30092; FLJ30208; FLJ34154; KIAA0614; MGC126531;
E. coli?Shiga-like toxin?II B subunit
E. coli Shiga-like toxin II B subunit
E. coli Shiga-like toxin II B; E. coli;
Host Cell Protein Mitigation
Recombinant protein drug products are often contaminated with proteins from the host cell system from which they were derived. Called host cell proteins (HCP), these contaminating proteins often co-purify along with the therapeutic protein from its growth media. There are thousands of HCP variants, ...
Ligand-Protein Interactions Screening Based on Gold Nanoparticles
Gold nanoparticles (AuNPs) are widely used as colorimetric probes for biosensing, relying on their unique particle size-dependent and/or interparticle distance dependent extinction spectrum and solution color. They have been extensively used as colorimetric probes for chemical and biological analysi...
Systematic Evolution of Ligands by Exponential Enrichment (SELEX)
The Systematic Evolution of Ligands by Exponential Enrichment (SELEX) is a combinatorial chemical technology developed in the 1990s. Using this technique, aptamers with high specific affinity for the target substance can be screened from a library of random single-stranded nucleic acid sequences, an...
